19 May 2013
Keywords: update, uk, nice, fast-track, herceptin, welcomed, government
Article | 01 August 2005
The UK government's decision to make an early referral of Genentech's Herceptin (trastuzumab), used in the treatment of early-stage breast ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.